Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020
April 09 2020 - 4:45PM
Conformis, Inc. (NASDAQ: CFMS) today announced that, due to
the public health impact of the novel coronavirus outbreak and
governmental restrictions limiting the number of people who may
gather together, and to support the health and well-being of its
stockholders, employees and communities, its 2020 annual meeting of
stockholders, to be held on Monday, April 27, 2020 at 4:30 p.m.
Eastern time, has been changed to a virtual meeting. Stockholders
will be able to participate in this year’s Annual Meeting only via
the virtual meeting.
Stockholders are entitled to participate in the Annual Meeting
if they were a stockholder at the close of business on February 27,
2020, the record date, or hold a legal proxy for the meeting
provided by the stockholder’s bank, broker or nominee as of such
record date.
The Annual Meeting will be accessible at
www.virtualshareholdermeeting.com/CFMS2020 (the
“Annual Meeting Website”). To access, participate in, and vote at
the Annual Meeting, stockholders must enter the control number
found on their proxy card, voting instruction form or notice
previously received. Stockholders may vote during the Annual
Meeting by following the instructions available on the Annual
Meeting Website. Those without a control number may attend as
guests of the meeting, but will not have the option to vote or ask
questions during the virtual meeting.
Further information regarding the change to the location of the
Annual Meeting can be found in the proxy supplement filed by the
Company with the Securities and Exchange Commission on April 9,
2020.
Please note that the proxy card included with the proxy
materials previously distributed will not be updated to reflect the
change in location and may continue to be used to vote your shares
in connection with the Annual Meeting.
All stockholders - whether attending the Annual Meeting or not -
are encouraged to vote and submit their proxies in advance of the
meeting by one of the methods described in the proxy materials.
Stockholders may also vote online during the Annual Meeting by
following the instructions available on the Annual Meeting
Website.
We intend to resume our historical practice of holding an
in-person meeting next year.
About Conformis, Inc.
Conformis is a medical technology company that uses its
proprietary iFit Image-to-Implant technology platform to develop,
manufacture, and sell joint replacement implants and instruments
that are individually sized and shaped, which we refer to as
personalized, individualized, or sometimes as customized, to fit
each patient's unique anatomy. Conformis offers a broad line of
sterile, personalized knee and hip implants and single-use
instruments delivered to hospitals. In clinical
studies, the Conformis iTotal CR knee replacement system
demonstrated superior clinical outcomes, including better function
and greater patient satisfaction, compared to traditional,
off-the-shelf implants. Conformis owns or exclusively
in-licenses issued patents and pending patent applications that
cover personalized implants and patient-specific instrumentation
for all major joints.
For more information, visit www.conformis.com. To
receive future releases in e-mail alerts, sign up
at ir.conformis.com.
CONTACT:
Investor contact
ir@conformis.com
(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024